In this study, we found that HIF‐1 and its associated factor CAIX induced chemoresistance of A549 cells and that these factors were associated with prognosis of stage IIIA advanced NSCLC patients after induction chemoradiotherapy. The gene discussed is CA9; the disease is non-small cell lung carcinoma.